会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明专利
    • Imidazo- and pyrrolo[1,2-A]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
    • NZ515460A
    • 2004-06-25
    • NZ51546000
    • 2000-05-12
    • NEUROCRINE BIOSCIENCES INC
    • ZHU YUN-FEIWILCOXEN KEITH MSTRUTHERS R SCOTTCHEN CHENCONNORS PATRICKGAO YINGHONGTUCCI FABIO C
    • A61K31/519A61P1/00A61P13/08A61P15/00A61P15/02A61P15/12A61P17/00A61P25/20A61P35/00A61P37/02C07D487/04A61K31/505
    • Gonadotrophin releasing hormone (GnRH) receptor antagonists of formula (I) wherein: m is an integer from 1 to 6; R1 is H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, aryl(CR3cR3d)n, substituted aryl(CR3cR3d)n, heteroaryl(CR3cR3d)n or substituted heteroaryl(CR3cR3d)n; R2 is H, alkyl or substituted alkyl; or R1 and R2 together with the N atom to which they are attached form a heterocycle ring or a substituted heterocycle ring; R3a, R3b, R3c and R3d are the same or different and independently H, alkyl, substituted alkyl, hydroxy, alkoxy, thioalkyl, amino, alkylamino, dialkylamino, cyano, halogen, -C(=O)OR7 or -C(=O)NR7R8; or R3a-3d together with the C atom to which they are attached form a carbocyclic ring or substituted carbocyclic ring; or R3a and R1 taken together with the C and N atom respectively to which they are attached form a heterocyclic ring or substituted heterocyclic ring; R4 is H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituterd arylalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl; R5 is H, halogen, cyano, alkyl, substituted alkyl, hydroxy, alkoxy, thioalkyl, or mono- or di-alkylamine; R6 is H, alkyl, substituted alkyl, aryl, substituted aryl, hetercycle, substituted heterocycle, -OR7, -SR7, -SOR7, -SO2R7, -OSO2R7, -SO2OR7, -SO2NR7R8, -NR9SO2R7, -C(=O0R7, -C(=O)OR7, -OC(=O)R7, -NR7R8 -C(=O)NR7R8, -OC(=O)NR7R8, -NR9C(=O)R7, -NR9C(=O)NR7R8, NR8C(=O)NR7 or -C(OH)R7R8; B and Ar are: B is N or CR10 when Ar is heteroaryl or substituted heteroaryl and R10 is H; or B is CR10 when Ar is aryl, substituted aryl, heteroaryl, or substituted heteroaryl and R10 is halogen, cyano, nitro, amino, mono- or di- alkylamino or alkyl. Also covered is the use of said compounds in the preparation of medicaments for the treatment of a sex-hormone related condition, wherein said condition is cancer, benign prostatic hypertrophy or myoma of the uterus.